Columns

MS news notes: Dalfampridine, Neural Sleeve, vitamin D

Welcome to “MS News Notes,” a column where I comment on multiple sclerosis (MS) news stories that caught my eye last week. Here’s a look at what’s been happening: Dalfampridine side effects The side effects that might occur if you use dalfampridine (sold under the brand name Ampyra)…

MS news notes: EBV, stopping a DMT, 3 treatment reports

Welcome to “MS News Notes,” a column where I comment on multiple sclerosis (MS) news stories that caught my eye last week. This week, the stories cover research presented at the joint meeting of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) and the…

MS news notes: Silent progression, ignoring treatments

Welcome to “MS News Notes,” a column where I comment on multiple sclerosis (MS) news stories that caught my eye last week. Here’s a look at what’s been happening: ‘Silent’ MS progression Readers of the MS News Today website and Facebook page sometimes wonder why their MS…

People with disabilities should be part of equity in healthcare

You’d think that people with multiple sclerosis (MS) and other disabilities would have easy access to healthcare services. That’s not always so. A small study in the journal Health Affairs that I wrote about last year said many physicians “expressed explicit bias toward people with disabilities and described…

And a good time was had by the sclerosis boys

I haven’t seen my mate Nige for years. Actually, to his face I call him Nigel, but it’s Nige when I, or anyone else, talk about him in the third person. It’s weird — I’d never thought about that before typing his name just now. And it’s not like he…

MS news notes: ANK-700, traveling for treatment, cognition

Welcome to “MS News Notes,” a column where I comment on multiple sclerosis (MS) news stories that caught my eye last week. Here’s a look at what’s been happening: An ‘inverse vaccine’ trial to treat MS What’s an “inverse vaccine,” you might ask? While traditional vaccines rev up…

A quiet MS week that’s just too darned loud to think

Big breath, for my travails below necessitate a catch-up on my story so far. For once, my multiple sclerosis and the myriad joyous comorbidities it’s conferred on me — trigeminal neuralgia, lymphedema, diplopia, spasticity — have given me a break. So have the fellow travelers who’ve…

MS news notes: Vaccines, migraines, eye-tracking technology

Welcome to “MS News Notes,” a column where I comment on multiple sclerosis (MS) news stories that caught my eye last week. Here’s a look at what’s been happening: Vaccines pose no unusual risk of MS hospitalization, study says It’s time for me to get my seasonal flu shot,…

Aggressive MS has me depressed for one whole day

How do you start a column about depression that isn’t, well, depressing? That’s a question for me to answer rather than you lot. If you’re still reading this week’s musings, then so far I’ve done pretty darned good. It was a confluence of events that fortunately involved water. I’d…

MS news notes: Bowel symptoms, MS blood test, diet study

Note: This column was updated Sept. 12, 2023, to correct that Octave’s MSDA blood test is currently available and in use throughout the U.S. Welcome to “MS News Notes,” a column where I comment on multiple sclerosis (MS) news stories that caught my eye last week. Here’s a look…